Search Results - "NOWIS, D"

Co-delivery of indoleamine 2,3-dioxygenase prevents loss of expression of an antigenic transgene in dystrophic mouse muscles by Sharma, D, Al-Khalidi, R, Edgar, S, An, Q, Wang, Y, Young, C, Nowis, D, Gorecki, D C

“…A significant problem affecting gene therapy approaches aiming at achieving long-term transgene expression is the immune response against the protein product…”
Get full text

Evidence of ER stress and UPR activation in patients with Brody disease and Brody syndrome by Guglielmi, V., Voermans, N. C., Oosterhof, A., Nowis, D., van Engelen, B. G., Tomelleri, G., Vattemi, G.

“…Brody disease (BD, OMIM #601003) is an inherited skeletal muscle disease clinically characterized by exercise-induced impairment of muscle relaxation and…”
Get full text

Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity by NOWIS, D, LEGAT, M, JOZKOWICZ, A, WAS, H, ADAMEK, M, WRZOSEK, A, NAZAREWSKI, S, MAKOWSKI, M, STOKŁOSA, T, JAKOBISIAK, M, GOŁAB, J, GRZELA, T, NIDERLA, J, WILCZEK, E, WILCZYNSKI, G. M, GŁODKOWSKA, E, MROWKA, P, ISSAT, T, DULAK, J

“…Photodynamic therapy is a promising antitumor treatment modality approved for the management of both early and advanced tumors. The mechanisms of its antitumor…”
Get full text

GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy by Firczuk, M, Gabrysiak, M, Barankiewicz, J, Domagala, A, Nowis, D, Kujawa, M, Jankowska-Steifer, E, Wachowska, M, Glodkowska-Mrowka, E, Korsak, B, Winiarska, M, Golab, J

“…Glucose-regulated protein 78 (GRP78) is an endoplasmic reticulum (ER)-resident chaperone and a major regulator of the unfolded protein response (UPR)…”
Get full text

22P Functional characterization of DIRC3 long non-coding RNA in differentiated thyroid cancer by Wysocki, P.T., Kolanowska, M., Nowis, D.

Get full text

CD71+ erythroid cells promote multiple myeloma progression and impair anti-bacterial immune response by Czubak, K, Grzywa, T M, Sidor-Dzitkowska, K, Pilch, Z, Bielak, K, Hoser, G, Gewartowska, O, Malecka-Gieldowska, M, Barankiewicz, J, Garbicz, F, Ciepiela, O, Juszczynski, P, Owczarek, A, Wegrzynowicz, M, Skirecki, T, Golab, J, Nowis, D

“…Multiple myeloma (MM), one of the most frequent haematological malignancies, significantly increases the risk of bacterial infections due to treatment-related…”
Get full text

RVU120, a small molecule inhibitor of CDK8/19 kinases, enhances rituximab-driven NK cells-mediated cytotoxicity both in vitro and in vivo by Białopiotrowicz-Data, E., Dziedzic, K., Podkalicka, P., Grycuk, K., Gołas, A., Dolata, I., Chmielewski, S., Pilch, Z., Nowis, D., Juszczyński, P., Rzymski, T.

Get full text

Abstract P3-09-07: The role of MLK4 amplification in progression of triple negative breast cancer by Prelowska, MK, Mehlich, D, Lazniewski, M, Kaminska, K, Gorczynski, AS, Korwat, A, Sokolowska, O, Golab, J, Biernat, W, Plewczynski, D, Brognard, J, Nowis, D, Marusiak, AA

“…Mixed Lineage Kinase 4 (MLK4) is a serine/threonine kinase that plays a role in a variety of cellular processes, including migration, apoptosis and…”
Get full text

Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy by Stanczak, P.S., Grzybowski, M.M., Wolska, P., Zdziarska, A.M., Mazurkiewicz, M., Blaszczyk, R., Nowicka, J., Sosnowska, A., Ramji, K., Nowis, D., Golab, J., Golebiowski, A., Dobrzanski, P., Dzwonek, K.

Get full text

Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy by Stanczak, P.S., Grzybowski, M.M., Wolska, P., Zdziarska, A.M., Mazurkiewicz, M., Blaszczyk, R., Nowicka, J., Sosnowska, A., Ramji, K., Nowis, D., Golab, J., Golebiowski, A., Dobrzanski, P., Dzwonek, K.

Get full text

Direct tumor damage mechanisms of photodynamic therapy by Nowis, Dominika, Makowski, Marcin, Stokłosa, Tomasz, Legat, Magdalena, Issat, Tadeusz, Gołab, Jakub

“…Photodynamic therapy (PDT) is a clinically approved and rapidly developing cancer treatment regimen. It is a minimally invasive two-stage procedure that…”
Get full text

Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells by JALILI, Ahmad, MAKOWSKI, Marcin, SIENKO, Jacek, SIERON, Aleksander, ADAMEK, Mariusz, BASAK, Grzegorz, MROZ, Pawet, KRASNODEBSKI, Ireneusz W, JAKOBISIAK, Marek, GOLAB, Jakub, SWITAJ, Tomasz, NOWIS, Dominika, WILCZYNSKI, Grzegorz M, WILCZEK, Ewa, CHORAZY-MASSALSKA, Magdalena, RADZIKOWSKA, Anna, MASLINSKI, Wlodzimierz, BIALY, Lukasz

“…Purpose: The unique mechanism of tumor destruction by photodynamic therapy (PDT), resulting from apoptotic and necrotic killing of tumor cells accompanied by…”
Get full text

Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor by Golab, Jakub, Nowis, Dominika, Skrzycki, Michal, Czeczot, Hanna, Baranczyk-Kuzma, Anna, Wilczynski, Grzegorz M, Makowski, Marcin, Mroz, Pawel, Kozar, Katarzyna, Kaminski, Rafal, Jalili, Ahmad, Kopec', Maciej, Grzela, Tomasz, Jakobisiak, Marek

“…Photodynamic therapy (PDT), a promising therapeutic modality for the management of solid tumors, is a two-phase treatment consisting of a photosensitizer and…”
Get full text

Sarcolemmal Ca2+-ATPase ability to transport Ca2+ gradually diminishes after myocardial infarction in the rat by Mackiewicz, Urszula, Maczewski, Michał, Konior, Anna, Tellez, James O., Nowis, Dominika, Dobrzynski, Halina, Boyett, Mark R., Lewartowski, Bohdan

“…Aims Plasmalemmal Ca2+-ATPase (PMCA) is involved in Ca2+ handling and the regulation of intracellular signalling pathways in the heart. However, there is no…”
Get full text

Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin by Kozar, Katarzyna, Kaminski, Rafal, Legat, Magdalena, Kopec, Maciej, Nowis, Dominika, Skierski, Janusz S, Koronkiewicz, Miroslawa, Jakóbisiak, Marek, Golab, Jakub

“…Competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase are commonly used in the clinic to treat hypercholesterolemia and have been…”
Get more information

Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cells by NOWIS, Dominika, LEGA, Magdalena, BIL, Jacek, KURZAJ, Zuzanna, ISSAT, Tadeusz, STOKLOSA, Tomasz, MIODUSZEWSKA, Barbara, KACZMAREK, Leszek, JAKOBISIAK, Marek, GOLAB, Jakub

“…Cisplatin, a widely used chemotherapeutic is approved for the management of various solid tumors. Administration of cisplatin is associated with induction of…”
Get full text

Lovastatin potentiates antitumor effects of saquinavir against human lymphoma cells by Issat, Tadeusz, Nowis, Dominika, Jakóbisiak, Marek, Golab, Jakub

“…Antiretroviral protease inhibitors have been shown to cause hyperlipidemia, raising concerns for the possibility of cardiovascular complications among…”
Get more information

CpG Immunostimulatory Oligodeoxynucleotide 1826 Enhances Antitumor Effect of Interleukin 12 Gene-Modified Tumor Vaccine in a Melanoma Model in Mice by SWITAJ, Tomasz, JALILI, Ahmad, SASOR, Agata, SOCHA, Koryna, JAKOBISIAK, Marek, LASEK, Witold, JAKUBOWSKA, Anna B, DRELA, Nadzieja, STOKSIK, Magdalena, NOWIS, Dominika, BASAK, Grzegorz, GOLAB, Jakub, WYSOCKI, Piotr J, MACKIEWICZ, Andrzej

“…Purpose: The effectiveness of interleukin (IL)-12-secreting tumor vaccines in the treatment of mouse tumors could be enhanced by concurrent application of…”
Get full text

In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor by Feleszko, Wojciech, Mlynarczuk, Izabela, Nowis, Dominika

Get full text

Rola szlaku sygnałowego MAPK/ERK w indukowaniu oporności na glikokortykosteroidy (GKS) w komórkach ostrej białaczki limfoblastycznej (OBL) by Polak, A., Kiliszek, P., Sewastianik, T., Szydłowski, M., Jabłońska, E., Białopiotrowicz, E., Górniak, P., Markowicz, S., Nowak, E., Grygorowicz, M.A., Nowis, D., Gołąb, J., Giebel, S., Lech-Marańda, E., Warzocha, K., Juszczyński, P.

Get full text